Including results for sangamo investor relations
Search only for sgmo investor relations
Investor Relations/Media. Louise Wilkie. (628) 252-7840 · IR@sangamo.com · media@sangamo.com. Transfer Agent. Computershare, Inc. 250 Royall Street Canton, MA ...
People also ask
What is the outlook for Sangamo Therapeutics?
How big is Sangamo Therapeutics?
What do Sangamo therapeutics do?
What is the history of Sangamo?
The Investor Relations website contains information about Sangamo Therapeutics, Inc.'s business for stockholders, potential investors, and financial ...
Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights ... Conference Call and Webcast Scheduled for 4:30 ...
BRISBANE, Calif. --(BUSINESS WIRE)--May 16, 2023-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of ...
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Access Sangamo Therapeutics Inc (SGMO) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using Quartr.
Get the latest insights on Sangamo Therapeutics, Inc. Common Stock (SGMO) with press releases and corporate news to help you in your trading and investing ...
Mar 14, 2024 · Louise Wilkie; Investor Relations; Sangamo Therapeutics Inc. Sandy Macrae; CEO; Sangamo Therapeutics Inc. Amy Pooler; Head of Research; ...
Nov 1, 2023 · SANGAMO THERAPEUTICS ANNOUNCES STRATEGIC UPDATE AND REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS. Contacts. Investor Relations & Media Inquiries
Mar 13, 2024 · Investor Relations & Media Inquiries Louise Wilkie ir@sangamo.com · media@sangamo.com. Source: Sangamo Therapeutics, Inc. Powered by Business ...